Expression of LIN28 and its regulatory microRNAs in adult adrenocortical cancer

Clinical Endocrinology

Volumn 82, Issue 4, 2015, Pages 481-488

  Faria, André M ^a   Sbiera, Silviu ^b   Ribeiro, Tamaya C ^a   Soares, Iberê C ^a,c   Mariani, Beatriz M P ^a   Freire, Daniel S ^a   De Sousa, Gabriela R V ^a   Lerario, Antônio M ^a   Ronchi, Cristina L ^b   Deutschbein, Timo ^b   Wakamatsu, Alda ^a   Alves, Venancio A F ^a   Zerbini, Maria Claudia N ^a   Mendonca, Berenice B ^a   Fragoso, Maria Candida B V ^a   Latronico, Ana Claudia ^a   Fassnacht, Martin ^b   Almeida, Madson Q ^a  

^a UNIVERSITY OF SÃO PAULO   (Brazil)

^b UNIVERSITY OF WÜRZBURG   (Germany)

^c Unidade Porto Velho   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

KI 67 ANTIGEN; LIN-28 PROTEIN, HUMAN; MICRORNA; RNA BINDING PROTEIN;

ADENOMA; ADRENAL CORTEX CARCINOMA; ADRENAL CORTEX TUMOR; ADULT; BRAZIL; COHORT ANALYSIS; COPY NUMBER VARIATION; DISEASE FREE SURVIVAL; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETIC ASSOCIATION; GENETICS; GERMANY; HUMAN; MALE; METABOLISM; MIDDLE AGED; PROGNOSIS; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; TUMOR RECURRENCE;

ADENOMA; ADRENAL CORTEX NEOPLASMS; ADRENOCORTICAL CARCINOMA; ADULT; BRAZIL; COHORT STUDIES; DISEASE-FREE SURVIVAL; DNA COPY NUMBER VARIATIONS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME-WIDE ASSOCIATION STUDY; GERMANY; HUMANS; KI-67 ANTIGEN; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; PROGNOSIS; REAL-TIME POLYMERASE CHAIN REACTION; RNA-BINDING PROTEINS; TREATMENT OUTCOME;

EID: 84937715597     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/cen.12607     Document Type: Article

References (36)

1. Fassnacht, M., Libe, R., Kroiss, M., et al,. (2011) Adrenocortical carcinoma: a clinician's update. Nature Reviews Endocrinology, 7, 323-335.
2. Fassnacht, M., Kroiss, M., &, Allolio, B., (2013) Update in adrenocortical carcinoma. The Journal of Clinical Endocrinology and Metabolism, 98, 4551-4564.
3. Else, T., Kim, A., Sabolch, A., et al,. (2014) Adrenocortical carcinoma. Endocrine Reviews, 35, 282-326.
4. Fassnacht, M., Terzolo, M., Allolio, B., et al,. (2012) Combination chemotherapy in advanced adrenocortical carcinoma. The New England Journal of Medicine, 366, 2189-2197.
5. Berruti, A., Baudin, E., Gelderblom, H., et al,. (2012) Adrenal cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Annals of Oncology, 23 (Suppl 7), vii131-vii138.
6. Almeida, M.Q., Fragoso, M.C., Lotfi, C.F., et al,. (2008) Expression of insulin-like growth factor-II and its receptor in pediatric and adult adrenocortical tumors. The Journal of Clinical Endocrinology and Metabolism, 93, 3524-3531.
7. Heaton, J.H., Wood, M.A., Kim, A.C., et al,. (2012) Progression to adrenocortical tumorigenesis in mice and humans through insulin-like growth factor 2 and beta-catenin. The American Journal of Pathology, 181, 1017-1033.
8. Faria, A.M., &, Almeida, M.Q., (2012) Differences in the molecular mechanisms of adrenocortical tumorigenesis between children and adults. Molecular and Cellular Endocrinology, 351, 52-57.
9. Calin, G.A., &, Croce, C.M., (2006) MicroRNA signatures in human cancers. Nature Reviews Cancer, 6, 857-866.
10. Singh, P., Soon, P.S., Feige, J.J., et al,. (2012) Dysregulation of microRNAs in adrenocortical tumors. Molecular and Cellular Endocrinology, 351, 118-128.
11. Patterson, E.E., Holloway, A.K., Weng, J., et al,. (2011) MicroRNA profiling of adrenocortical tumors reveals miR-483 as a marker of malignancy. Cancer, 117, 1630-1639.
12. Soon, P.S., Tacon, L.J., Gill, A.J., et al,. (2009) miR-195 and miR-483-5p identified as predictors of poor prognosis in adrenocortical cancer. Clinical Cancer Research: An Official Journal of the American Association for Cancer Research, 15, 7684-7692.
13. Viswanathan, S.R., &, Daley, G.Q., (2010) Lin28: a microRNA regulator with a macro role. Cell, 140, 445-449.
14. Zhou, J., Ng, S.B., &, Chng, W.J., (2013) LIN28/LIN28B: an emerging oncogenic driver in cancer stem cells. The International Journal of Biochemistry & Cell Biology, 45, 973-978.
15. Zhong, X., Li, N., Liang, S., et al,. (2010) Identification of microRNAs regulating reprogramming factor LIN28 in embryonic stem cells and cancer cells. The Journal of Biological Chemistry, 285, 41961-41971.
16. Viswanathan, S.R., Powers, J.T., Einhorn, W., et al,. (2009) Lin28 promotes transformation and is associated with advanced human malignancies. Nature Genetics, 41, 843-848.
17. Wang, Y.C., Chen, Y.L., Yuan, R.H., et al,. (2010) Lin-28B expression promotes transformation and invasion in human hepatocellular carcinoma. Carcinogenesis, 31, 1516-1522.
18. Alajez, N.M., Shi, W., Wong, D., et al,. (2012) Lin28b promotes head and neck cancer progression via modulation of the insulin-like growth factor survival pathway. Oncotarget, 3, 1641-1652.
19. Wilbert, M.L., Huelga, S.C., Kapeli, K., et al,. (2012) LIN28 binds messenger RNAs at GGAGA motifs and regulates splicing factor abundance. Molecular Cell, 48, 195-206.
20. Huang, Y., (2012) A mirror of two faces: Lin28 as a master regulator of both miRNA and mRNA. Wiley Interdisciplinary Reviews RNA, 3, 483-494.
21. Polesskaya, A., Cuvellier, S., Naguibneva, I., et al,. (2007) Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Genes & Development, 21, 1125-1138.
22. Shi, S.R., Key, M.E., &, Kalra, K.L., (1991) Antigen retrieval in formalin-fixed, paraffin-embedded tissues: an enhancement method for immunohistochemical staining based on microwave oven heating of tissue sections. The Journal of Histochemistry and Cytochemistry: Official Journal of the Histochemistry Society, 39, 741-748.
23. Olaussen, K.A., Dunant, A., Fouret, P., et al,. (2006) DNA repair by ERCC1 in non-small-cell lung cancer and cisplatin-based adjuvant chemotherapy. The New England Journal of Medicine, 355, 983-991.
24. Almeida, M.Q., Soares, I.C., Ribeiro, T.C., et al,. (2010) Steroidogenic factor 1 overexpression and gene amplification are more frequent in adrenocortical tumors from children than from adults. The Journal of Clinical Endocrinology and Metabolism, 95, 1458-1462.
25. Piskounova, E., Polytarchou, C., Thornton, J.E., et al,. (2011) Lin28A and Lin28B inhibit let-7 microRNA biogenesis by distinct mechanisms. Cell, 147, 1066-1079.
26. Duregon, E., Molinaro, L., Volante, M., et al,. (2014) Comparative Diagnostic and Prognostic Performances of the Hematoxylin-Eosin and Phospho-histone H3 Mitotic Count and Ki-67 Index in Adrenocortical Carcinoma. Modern pathology: an official journal of the United States and Canadian Academy of Pathology, Inc., 27, 1246-1254.
27. Krupp, M., Itzel, T., Maass, T., et al,. (2013) Cell LineNavigator: a workbench for cancer cell line analysis. Nucleic Acids Research, 41 (Database issue), D942-D948.
28. Giordano, T.J., Kuick, R., Else, T., et al,. (2009) Molecular classification and prognostication of adrenocortical tumors by transcriptome profiling. Clinical Cancer Research, 15, 668-676.
29. Ma, L., Young, J., Prabhala, H., et al,. (2010) miR-9, a MYC/MYCN-activated microRNA, regulates E-cadherin and cancer metastasis. Nature Cell Biology, 12, 247-256.
30. Sun, Z., Han, Q., Zhou, N., et al,. (2013) MicroRNA-9 enhances migration and invasion through KLF17 in hepatocellular carcinoma. Molecular Oncology, 7, 884-894.
31. Tang, H., Yao, L., Tao, X., et al,. (2013) miR-9 functions as a tumor suppressor in ovarian serous carcinoma by targeting TLN1. International Journal of Molecular Medicine, 32, 381-388.
32. Zheng, L., Qi, T., Yang, D., et al,. (2013) microRNA-9 suppresses the proliferation, invasion and metastasis of gastric cancer cells through targeting cyclin D1 and Ets1. PLoS ONE, 8, e55719.
33. Gupta, D., Shidham, V., Holden, J., et al,. (2001) Value of topoisomerase II alpha, MIB-1, p53, E-cadherin, retinoblastoma gene protein product, and HER-2/neu immunohistochemical expression for the prediction of biologic behavior in adrenocortical neoplasms. Applied Immunohistochemistry & Molecular Morphology: AIMM / Official Publication of the Society for Applied Immunohistochemistry, 9, 215-221.
34. Zhuang, G., Wu, X., Jiang, Z., et al,. (2012) Tumour-secreted miR-9 promotes endothelial cell migration and angiogenesis by activating the JAK-STAT pathway. The EMBO Journal, 31, 3513-3523.
35. Chabre, O., Libe, R., Assie, G., et al,. (2013) Serum miR-483-5p and miR-195 are predictive of recurrence risk in adrenocortical cancer patients. Endocrine-Related Cancer, 20, 579-594.
36. Janssen, H.L., Reesink, H.W., Lawitz, E.J., et al,. (2013) Treatment of HCV infection by targeting microRNA. The New England Journal of Medicine, 368, 1685-1694.